Nasal delivery as a strategy for the prevention and treatment of COVID-19.

Sonvico, Fabio; Colombo, Gaia; Quarta, Eride; Guareschi, Fabiola; Banella, Sabrina; Buttini, Francesca; Scherließ, Regina

Sonvico, Fabio; Colombo, Gaia; Quarta, Eride; Guareschi, Fabiola; Banella, Sabrina; Buttini, Francesca; Scherließ, Regina.

Afiliação

Sonvico F; Department of Food and Drug, University of Parma, Parma, Italy.
Colombo G; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Quarta E; Department of Food and Drug, University of Parma, Parma, Italy.
Guareschi F; Department of Food and Drug, University of Parma, Parma, Italy.
Banella S; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Buttini F; Department of Food and Drug, University of Parma, Parma, Italy.
Scherließ R; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.

Expert Opin Drug Deliv ; 20(8): 1115-1130, 2023.

Article em En | MEDLINE | ID: mdl-37755135

Assuntos

COVID-19; Mucosa Nasal; Humanos; COVID-19/prevenção & controle; Administração Intranasal; Sistemas de Liberação de Medicamentos; Antivirais/uso terapêutico

Palavras-chave

Antiviral nasal products; SARS-CoV-2 infection; barrier nasal products; mucosal delivery; nasal vaccine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mucosa Nasal Limite: Humans Idioma: En Revista: Expert Opin Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google